• Home/
  • Publications/
  • i/
  • item/
  • Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine

Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine

17 March 2021
 | COVID-19: Vaccines
Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine
Download (1 MB)

Overview

This background document on the Janssen Ad26.COV2.S (COVID-19) vaccine has been prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of Experts (SAGE) on Immunization to inform SAGE deliberations. It contains the evidence summary which was considered by SAGE and served as the foundation for the WHO Interim recommendations for use of the Janssen Ad26.COV2.S (COVID-19) vaccine referenced below. 

Related document:

Interim recommendations for the use of the Janssen Ad26.COV2.S

 

WHO Team
Immunization, Vaccines and Biologicals (IVB), WHO Headquarters (HQ)
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/Ad26.COV2.S/background/2021.1
Copyright